Welcome to the November edition of the Baker McKenzie Ukraine Healthcare Newsletter. This is your regular digest of legal developments affecting the life science and healthcare industries in Ukraine.
This edition covers the expected revision of the National Essential Medicines List and extension of the reimbursement program, an update on the progress of the healthcare reform, amendments of the simplified procedure for registration of pharmaceuticals, publication of the Typical Requirements to Vertical Concerted Actions of Business Entities, new major fines imposed by the Antimonopoly Committee of Ukraine on a pharmaceutical company and its distributors in Ukraine and the pension reform. More details on these developments affecting the Ukrainian life science and healthcare industries are provided below.
In This Issue
- Public procurement & reimbursement
- Registration of pharmaceuticals
- Healthcare system reform
- Competition law